All

Download Certificates for Credit Here.

0
No votes yet

Please review the entire page to register for this activity. Release Date: March 16, 2015 Expiration Date: April 16, 2015 Program Format: Internet Live Multimedia Fee There is no fee associated with this activity. Activity Description: The Southeast Lipid Association (SELA) in... more

0
No votes yet

As I look back at our recent Board of Directors meeting in Anaheim, I am reminded of how fortunate I am to serve as the National Lipid Association President with such a wonderful, dignified collection of leaders committed to advancing clinical lipidology. The NLA continues to mature, and to... more

0
No votes yet

The National Lipid Association (NLA) today announced the publication of a new meta-analysis evaluating the impact of low-density lipoprotein cholesterol (LDL-C) lowering on major adverse cardiovascular events (MACE) in primary prevention populations. The study synthesizes data from randomized... more

Section:

0
No votes yet

Risk assessment tools and lifestyle surveys can play a major role in screening patients for risk of atherosclerotic cardiovascular disease (ASCVD), allowing for early targeted interventions. It is known that race can greatly impact risk, yet it isn’t incorporated in all risk calculators. Similarly... more

0
No votes yet

Thank you for visiting the Pediatric (PedAL) Working Group Discussion Forum. We're glad you're here and hope you will participate, enjoy  and learn from the interaction here. In order to keep this forum useful and enjoyable for all involved, we'd like to ask that you observe the... more

0
No votes yet

Esperion has announced that NEXLIZET™ (bempedoic acid and ezetimibe) Is now available in pharmacies in the United States. NEXLIZET™ is an oral, once-daily, fixed-dose combination tablet indicated as an adjunct to diet and maximally tolerated statin for the treatment of adults with heterozygous... more

Section:

0
No votes yet

We have been consulted to see a 22 m/o infant who has an unresectable hepatoblastoma with multiple lung metastases.  The child is enrolled in an IND protocol using vincristine, irinotecan, and temsirolimus. Prior to induction, the total cholesterol was 345 mg/dl, with HDL-C 38 mg/dl, LDL-C... more

0
No votes yet